» Articles » PMID: 17207145

Trial Participation and Vaccine Desirability for Vi Polysaccharide Typhoid Fever Vaccine in Hue City, Viet Nam

Abstract

Objectives: To identify demand for Vi typhoid fever vaccine for school-age children; obstacles and enabling factors for vaccine delivery; and socio-behavioural factors associated with trial participation and possible predictors of future vaccine acceptance, in Hue City, Viet Nam.

Methods: Pre- and post-trial surveys of randomly selected households with children aged 6-17 years. Simple multinomial logistic analyses for ratios of relative risks (RRR) and significance on trial participation by demographics and variables related to typhoid fever, vaccination, and pre-trial experiences with information and consents. Multiple logistic regressions to assess differences in participation based on child's characteristics.

Results: As many as 62.6% of households let all school age children participate, 10.2% let some participate, and 26.8% let none of their children participate in the trial. Factors associated with all children participating included past use of healthcare facilities (RRR, 0.45; 95% CI, 0.24-0.83), knowledge of vaccines (RRR, 0.17; 95% CI, 0.03-0.86), and perceived causes of typhoid fever (RRR, 0.90; 95% CI, 0.81-0.99). Factors associated with some children participating included utilization of healthcare facilities (RRR, 0.08; 95% CI, 0.01-0.66) and perceived severity of typhoid fever (RRR, 0.64; 95% CI 0.46-0.88). Participation was associated with satisfaction regarding pre-vaccination information and consent procedures. Children and adolescents were active decision-makers. Only 14 of 461 (2.2%) respondents would not use the Vi vaccine in the future for their child(ren).

Conclusions: Inter-related factors contribute to participation in a clinical vaccine trial, which may differ from desire to participate in a public health campaign. Educational campaigns need to be targeted to children and adolescents, and consideration for assent procedures for minors. Obtaining informed consent may affect trial participation within a social and political system unaccustomed to these procedures.

Citing Articles

COVID-19 vaccination up-take in three districts of Nepal.

Pokhrel T, Karki K, Tinkari B, Upreti S, Khatiwada S, Amatya R Hum Vaccin Immunother. 2023; 19(1):2166321.

PMID: 36691997 PMC: 9988332. DOI: 10.1080/21645515.2023.2166321.


The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.

Browne J, Rees C, van Delden J, Agyepong I, Grobbee D, Edwin A Trop Med Int Health. 2018; 24(3):264-279.

PMID: 30565381 PMC: 6850431. DOI: 10.1111/tmi.13195.


Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.

Kufa T, Chihota V, Charalambous S, Verver S, Churchyard G Public Health Action. 2015; 3(1):31-7.

PMID: 26392993 PMC: 4463096. DOI: 10.5588/pha.12.0102.


Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.

Kar S, Pach A, Sah B, Kerketta A, Patnaik B, Mogasale V Hum Vaccin Immunother. 2014; 10(10):2834-42.

PMID: 25483631 PMC: 5443101. DOI: 10.4161/21645515.2014.971655.


Formative investigation of acceptability of typhoid vaccine during a typhoid fever outbreak in Neno District, Malawi.

Blum L, Dentz H, Chingoli F, Chilima B, Warne T, Lee C Am J Trop Med Hyg. 2014; 91(4):729-37.

PMID: 25002303 PMC: 4183395. DOI: 10.4269/ajtmh.14-0067.